U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Ampicillin and Sulbactam For Injection USP 3 Grams Due to The Presence of Visible Particulate Matter
  1. Recalls, Market Withdrawals, & Safety Alerts

COMPANY ANNOUNCEMENT

Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Ampicillin and Sulbactam For Injection USP 3 Grams Due to The Presence of Visible Particulate Matter

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Drugs
Generic Drugs
Reason for Announcement:
Recall Reason Description
Visible Particulate Matter
Company Name:
AuroMedics Pharma LLC
Brand Name:
Brand Name(s)
AuroMedics Pharma LLC
Product Description:
Product Description
Ampicillin and Sulbactam for Injection USP, 3 grams/ Single-Dose vial

Company Announcement

AuroMedics Pharma LLC is voluntarily recalling two lots of Ampicillin and Sulbactam for Injection USP, 3 grams*/ Single-Dose vial, to the hospital/user level. The recall has been initiated due to customer complaints of the presence of red particulate matter in the product that is believed to be red rubber particles from the manufacturing process of the active ingredients.

Risk Statement: In the event the particulate is administered to the patient, it may result in local site reaction, phlebitis, pulmonary granuloma, occlusion of blood vessels, thromboembolic events and systemic immune response. Patients with vascular disease may be at particular risk of embolic events which could cause permanent impairment or damage to a body structure or function. The risk is reduced by the possibility of detection. To date, AuroMedics Pharma LLC has not received reports of any adverse events or identifiable safety concerns attributed to the product consumed from these lots.

Ampicillin and Sulbactam for Injection is an intravenously or intramuscularly administered antibiotic used for the treatment of infections due to susceptible strains in adults and pediatric patients one year and older. It is packaged in a carton containing 10 vials, NDC  55150-117-20. The affected Ampicillin and Sulbactam for Injection lots being recalled are AS0317041-A, Exp. Aug 2019, and AS0317035-A, Exp. Aug 2019. The product can be identified as a ‘clear vial stoppered with grey rubber stopper and sealed with aluminum seals having a Royal Blue color polypropylene disc’. A ur oM e di c s shipped the entire lot to wholesalers and/or hospitals nationwide in the USA between Oct 19, 2017, through Oct 26, 2017.

The product label is as shown below:

AuroMedics Pharma LLC is notifying its distributors and customers by recall letters and is arranging for return/replacement etc. of all recalled product. Consumers/distributors/retailers that have the product lot which is being recalled should immediately stop using and return to place of purchase/contact their doctor as appropriate.

Consumers with questions regarding this recall can contact AuroMedics Customer Service Monday through Friday 9:00 AM to 5:00 PM EST at 888-238-7880 Option 1.  If you need assistance in returning your product or have questions about the  recall process, contact Inmar at 800-967-5952 Monday through Friday 8:30 AM to  5:00 PM EST. Consumers should contact their physician or healthcare provider if they have  experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

 


Company Contact Information

Consumers:
AuroMedics Customer Service
(888) 238-7880

Product Photos

Back to Top